Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.
Jama Oncology
Cobain, Erin F EF; Wu, Yi-Mi YM; Vats, Pankaj P; Chugh, Rashmi R; Worden, Francis F; Smith, David C DC; Schuetze, Scott M SM; Zalupski, Mark M MM; Sahai, Vaibhav V; Alva, Ajjai A; Schott, Anne F AF; Caram, Megan E V MEV; Hayes, Daniel F DF; Stoffel, Elena M EM; Jacobs, Michelle F MF; Kumar-Sinha, Chandan C; Cao, Xuhong X; Wang, Rui R; Lucas, David D; Ning, Yu Y; Rabban, Erica E; Bell, Janice J; Camelo-Piragua, Sandra S; Udager, Aaron M AM; Cieslik, Marcin M; Lonigro, Robert J RJ; Kunju, Lakshmi P LP; Robinson, Dan R DR; Talpaz, Moshe M; Chinnaiyan, Arul M AM
MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas.
British Journal Of Cancer
Kämpjärvi, Kati K; Mäkinen, Netta N; Mehine, Miika M; Välipakka, Salla S; Uimari, Outi O; Pitkänen, Esa E; Heinonen, Hanna-Riikka HR; Heikkinen, Tuomas T; Tolvanen, Jaana J; Ahtikoski, Anne A; Frizzell, Norma N; Sarvilinna, Nanna N; Sjöberg, Jari J; Bützow, Ralf R; Aaltonen, Lauri A LA; Vahteristo, Pia P